{"pmid":32470604,"title":"A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.","text":["A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.","We report a patient who had travelled to Japan presented mild respiratory symptom during the COVID-19 infection outbreak period. There was transient existence of SARS-CoV-2 RNA in his oropharynx. The RNA was absent in the six respiratory specimens that were subsequently tested. Anti-SARS-CoV-2 antibody response in the acute and convalescent sera were absent. The reported case indicates that transient colonization of SARS-CoV-2 in the upper respiratory tract is possible without inciting any antibody response against the virus.","Int J Infect Dis","Lin, Yi-Chun","Cheng, Chien-Yu","Cheng-Pin, Chen","Cheng, Shu-Hsing","Chang, Sui-Yuan","Hsueh, Po-Ren","32470604"],"abstract":["We report a patient who had travelled to Japan presented mild respiratory symptom during the COVID-19 infection outbreak period. There was transient existence of SARS-CoV-2 RNA in his oropharynx. The RNA was absent in the six respiratory specimens that were subsequently tested. Anti-SARS-CoV-2 antibody response in the acute and convalescent sera were absent. The reported case indicates that transient colonization of SARS-CoV-2 in the upper respiratory tract is possible without inciting any antibody response against the virus."],"journal":"Int J Infect Dis","authors":["Lin, Yi-Chun","Cheng, Chien-Yu","Cheng-Pin, Chen","Cheng, Shu-Hsing","Chang, Sui-Yuan","Hsueh, Po-Ren"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470604","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ijid.2020.05.070","keywords":["asymptomatic infection","covid-19","colonization","contamination","sars-cov-2"],"locations":["Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Case Report"],"weight":1,"_version_":1668167109888180225,"score":9.490897,"similar":[{"pmid":32369214,"title":"Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies.","text":["Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies.","The number of hospitalized cases has declined significantly in Wuhan. However, there have been reports that several cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients, the potential reasons of re-detectable positive patients remained elusive. Here, we report three confirmed cases of COVID-19 whose IgM was negative and IgG was positive before the first discharge, while nasopharyngeal swab test of SARS-CoV-2 RNA turned positive again during hotel isolation. In addition, all three cases presented negative results for IgM antibodies and positive results for IgG antibodies during re-admission period. These cases suggested that the reasons for re-detectable positive patients with profile of antibodies may be related to several factors. It is necessary to quarantine COVID-19 patients for 14 days after discharge, and the role of antibodies in anti-SARS-CoV-2 warrants further investigation. This article is protected by copyright. All rights reserved.","J Med Virol","Fu, Wei","Chen, Qian","Wang, Tao","32369214"],"abstract":["The number of hospitalized cases has declined significantly in Wuhan. However, there have been reports that several cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients, the potential reasons of re-detectable positive patients remained elusive. Here, we report three confirmed cases of COVID-19 whose IgM was negative and IgG was positive before the first discharge, while nasopharyngeal swab test of SARS-CoV-2 RNA turned positive again during hotel isolation. In addition, all three cases presented negative results for IgM antibodies and positive results for IgG antibodies during re-admission period. These cases suggested that the reasons for re-detectable positive patients with profile of antibodies may be related to several factors. It is necessary to quarantine COVID-19 patients for 14 days after discharge, and the role of antibodies in anti-SARS-CoV-2 warrants further investigation. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Fu, Wei","Chen, Qian","Wang, Tao"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369214","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/jmv.25968","keywords":["antibody","covid-19","rna","sars-cov-2"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138496138477570,"score":172.21368},{"pmid":32330293,"title":"Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.","text":["Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.","As an emerging infectious disease, the clinical course and virological course of SARS-CoV-2 infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with clinical course more than two months. This patient had recovered from the pneumonia after treatment. The viral RNA of throat swabs became negative and the viral specific antibodies were produced during recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral specific antibodies may imply an immune evasion of SARAS-CoV-2 from host's immune system. This article is protected by copyright. All rights reserved.","J Med Virol","Yang, Jian-Rong","Deng, Dao-Ting","Wu, Nan","Yang, Bin","Li, Hong-Juan","Pan, Xiao-Ben","32330293"],"abstract":["As an emerging infectious disease, the clinical course and virological course of SARS-CoV-2 infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with clinical course more than two months. This patient had recovered from the pneumonia after treatment. The viral RNA of throat swabs became negative and the viral specific antibodies were produced during recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral specific antibodies may imply an immune evasion of SARAS-CoV-2 from host's immune system. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yang, Jian-Rong","Deng, Dao-Ting","Wu, Nan","Yang, Bin","Li, Hong-Juan","Pan, Xiao-Ben"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330293","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25940","keywords":["coronavirus","sars-cov-2","saliva","virus shedding"],"topics":["Case Report"],"weight":1,"_version_":1666138494704025601,"score":159.44579},{"pmid":32251791,"pmcid":"PMC7195378","title":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.","text":["A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.","Novel coronavirus (SARS-Coronavirus-2:SARS-CoV-2) which emerged in Wuhan, China, has spread to multiple countries rapidly. We report the first case of meningitis associated with SARS-CoV-2 who was brought in by ambulance due to a convulsion accompanied by unconsciousness. He had never been to any foreign countries. He felt generalized fatigue and fever (day 1). He saw doctors nearby twice (day 2 and 5) and was prescribed Laninamivir and antipyretic agents, His family visited his home and found that he was unconsciousness and lying on the floor in his vomit. He was immediately transported to this hospital by ambulance (day 9). Under emergency transport, he had transient generalized seizures that lasted about a minute. He had obvious neck stiffness. The specific SARS-CoV-2 RNA was not detected in the nasopharyngeal swab but was detected in a CSF. Anti- HSV 1 and varicella-zoster IgM antibodies were not detected in serum samples. A brain MRI showed hyperintensity along the wall of right lateral ventricle and hyperintense signal changes in the right mesial temporal lobe and hippocampus, suggesting the possibility of SARS-CoV-2 meningitis. This case warns the physicians of patients who have CNS symptoms.","Int J Infect Dis","Moriguchi, Takeshi","Harii, Norikazu","Goto, Junko","Harada, Daiki","Sugawara, Hisanori","Takamino, Junichi","Ueno, Masateru","Sakata, Hiroki","Kondo, Kengo","Myose, Natsuhiko","Nakao, Atsuhito","Takeda, Masayuki","Haro, Hirotaka","Inoue, Osamu","Suzuki-Inoue, Katsue","Kubokawa, Kayo","Ogihara, Shinji","Sasaki, Tomoyuki","Kinouchi, Hiroyuki","Kojin, Hiroyuki","Ito, Masami","Onishi, Hiroshi","Shimizu, Tatsuya","Sasaki, Yu","Enomoto, Nobuyuki","Ishihara, Hiroshi","Furuya, Shiomi","Yamamoto, Tomoko","Shimada, Shinji","32251791"],"abstract":["Novel coronavirus (SARS-Coronavirus-2:SARS-CoV-2) which emerged in Wuhan, China, has spread to multiple countries rapidly. We report the first case of meningitis associated with SARS-CoV-2 who was brought in by ambulance due to a convulsion accompanied by unconsciousness. He had never been to any foreign countries. He felt generalized fatigue and fever (day 1). He saw doctors nearby twice (day 2 and 5) and was prescribed Laninamivir and antipyretic agents, His family visited his home and found that he was unconsciousness and lying on the floor in his vomit. He was immediately transported to this hospital by ambulance (day 9). Under emergency transport, he had transient generalized seizures that lasted about a minute. He had obvious neck stiffness. The specific SARS-CoV-2 RNA was not detected in the nasopharyngeal swab but was detected in a CSF. Anti- HSV 1 and varicella-zoster IgM antibodies were not detected in serum samples. A brain MRI showed hyperintensity along the wall of right lateral ventricle and hyperintense signal changes in the right mesial temporal lobe and hippocampus, suggesting the possibility of SARS-CoV-2 meningitis. This case warns the physicians of patients who have CNS symptoms."],"journal":"Int J Infect Dis","authors":["Moriguchi, Takeshi","Harii, Norikazu","Goto, Junko","Harada, Daiki","Sugawara, Hisanori","Takamino, Junichi","Ueno, Masateru","Sakata, Hiroki","Kondo, Kengo","Myose, Natsuhiko","Nakao, Atsuhito","Takeda, Masayuki","Haro, Hirotaka","Inoue, Osamu","Suzuki-Inoue, Katsue","Kubokawa, Kayo","Ogihara, Shinji","Sasaki, Tomoyuki","Kinouchi, Hiroyuki","Kojin, Hiroyuki","Ito, Masami","Onishi, Hiroshi","Shimizu, Tatsuya","Sasaki, Yu","Enomoto, Nobuyuki","Ishihara, Hiroshi","Furuya, Shiomi","Yamamoto, Tomoko","Shimada, Shinji"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251791","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ijid.2020.03.062","keywords":["covid-19","infections","meningitis","polymerase chain reaction","sars-cov-2"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["R 125489"],"topics":["Case Report"],"weight":1,"_version_":1666138490985775104,"score":154.1346},{"pmid":32484958,"title":"Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients.","text":["Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients.","COVID-19 patients may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the SARS-CoV-2 viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative RT-PCR tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than two weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead. This article is protected by copyright. All rights reserved.","J Med Virol","Carmo, Analia","Pereira-Vaz, Joao","Mota, Vanda","Mendes, Alexandra","Morais, Celia","da Silva, Andreia Coelho","Camilo, Elisabete","Pinto, Catarina Silva","Cunha, Elizabete","Pereira, Janet","Coucelo, Margarida","Martinho, Patricia","Correia, Lurdes","Marques, Gilberto","Araujo, Lucilia","Rodrigues, Fernando","32484958"],"abstract":["COVID-19 patients may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the SARS-CoV-2 viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative RT-PCR tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than two weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Carmo, Analia","Pereira-Vaz, Joao","Mota, Vanda","Mendes, Alexandra","Morais, Celia","da Silva, Andreia Coelho","Camilo, Elisabete","Pinto, Catarina Silva","Cunha, Elizabete","Pereira, Janet","Coucelo, Margarida","Martinho, Patricia","Correia, Lurdes","Marques, Gilberto","Araujo, Lucilia","Rodrigues, Fernando"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484958","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26103","keywords":["covid-19","rt-pcr","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1668532114697486336,"score":152.13588},{"pmid":32320384,"title":"Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.","text":["Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.","BACKGROUND: Anti-SARS-CoV-2 virus antibody levels in convalescent plasma (CP), which may be useful in severe Anti-SARS-CoV-2 virus infections, have been rarely reported. RESULTS: A total of eight donors were considered for enrollment; two of them were excluded because of ineligible routine check. Of the six remaining participants, five samples were tested weakly positive by the IgM ELISA. Meanwhile, high titers of IgG were observed in five samples. The patient treated with CP did not require mechanical ventilation 11 days after plasma transfusion, and was then transferred to a general ward. CONCLUSIONS: Our serological findings in convalescent plasma from recovered patients may help facilitate understanding of the SARS-CoV-2 infection and establish CP donor screening protocol in COVID-19 outbreak. METHODS: Anti-SARS-CoV-2 antibodies including IgM and IgG were measured by two enzyme-linked immunosorbent assays (ELISA) in convalescent plasma from six donors who have recovered from coronavirus disease 2019 (COVID-19) in Nanjing, China. CP was also utilized for the treatment of one severe COVID-19 patient.","Aging (Albany NY)","Zhang, Libo","Pang, Rongrong","Xue, Xiang","Bao, Jingjing","Ye, Sheng","Dai, Yudong","Zheng, Yishan","Fu, Qiang","Hu, Zhiliang","Yi, Yongxiang","32320384"],"abstract":["BACKGROUND: Anti-SARS-CoV-2 virus antibody levels in convalescent plasma (CP), which may be useful in severe Anti-SARS-CoV-2 virus infections, have been rarely reported. RESULTS: A total of eight donors were considered for enrollment; two of them were excluded because of ineligible routine check. Of the six remaining participants, five samples were tested weakly positive by the IgM ELISA. Meanwhile, high titers of IgG were observed in five samples. The patient treated with CP did not require mechanical ventilation 11 days after plasma transfusion, and was then transferred to a general ward. CONCLUSIONS: Our serological findings in convalescent plasma from recovered patients may help facilitate understanding of the SARS-CoV-2 infection and establish CP donor screening protocol in COVID-19 outbreak. METHODS: Anti-SARS-CoV-2 antibodies including IgM and IgG were measured by two enzyme-linked immunosorbent assays (ELISA) in convalescent plasma from six donors who have recovered from coronavirus disease 2019 (COVID-19) in Nanjing, China. CP was also utilized for the treatment of one severe COVID-19 patient."],"journal":"Aging (Albany NY)","authors":["Zhang, Libo","Pang, Rongrong","Xue, Xiang","Bao, Jingjing","Ye, Sheng","Dai, Yudong","Zheng, Yishan","Fu, Qiang","Hu, Zhiliang","Yi, Yongxiang"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320384","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.18632/aging.103102","keywords":["covid-19","sars-cov-2 virus","anti-sars-cov-2 antibodies","convalescent plasma","coronavirus disease 2019","plasma donation"],"locations":["Nanjing","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138493620846594,"score":148.50513}]}